Company announces $30 million Series A financing and founding leadership team with expertise in pulmonary drug innovation and track record advancing novel therapies to patients ORJ-001, set to begin a ...

Annovis Bio (ANVS) shares fell over -7% on Wednesday after the biotechnology company priced an offering to raise approximately $15M. The offering consists of 7,895,000 shares of its common stock and ...

University of Pennsylvania spinout Passage Bio plans to cut 75% of its staff as the firm continues to review strategic ...

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks by share price growth this year, four were bio·healthcare-related. Seers Technology, an AI medical device company, saw its ...

Finnish company Onego Bio receives FDA approval for Bioalbumen, its animal-free egg protein, paving the way for U.S. commercialization. Finnish food technology company Onego Bio plans to spend between ...

While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth. On GEN Live, we’ll talk to Syn Bio ...

Company evaluating potential acquisitions and in-licensing opportunities to drive next phase of strategic development Cash position of $76.3 million as of December 31, 2025 expected to fund current ...

DALLAS, Texas--(BUSINESS WIRE)--Colossal Biosciences, the de-extinction company behind the woolly mammoth and thylacine, today announced the launch of Form Bio, a new independent company offering a ...

NOOSAVILLE, Australia--(BUSINESS WIRE)--Provectus Algae (Provectus) has secured an undisclosed strategic investment from CJ BIO, a division of South Korea-based food & bio company CJ CheilJedang.

Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has entered into a securities purchase agreement ...